JPRN-UMIN000014760已完成未知
Preliminary study detecting of plasma soluble PD-L1 in the patients with advanced lung cancer - soluble PD-L1 with advanced lung cancer
Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital0 个研究点目标入组 96 人开始时间: 2014年8月30日最近更新:
适应症
试验速览
研究概览
简要总结
The implication of soluble PD-L1 (sPD-L1) in lung cancer patients remains unknown. The present study demonstrated that high levels of sPD-L1 was associated with poor prognosis in advanced lung cancer. sPD-L1 may be a useful biomarker for immune checkpoint therapy.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Other than that above
研究者
相似试验
已完成
不适用
The Correlation of PD-L1 Expression in Non-small Lung Cancer Tissue and Peripheral Blood T Cell and Serum.NSCLCNCT03073902Xinqiao Hospital of Chongqing80
已完成
不适用
The Role of Programmed Death Ligand -1 (Pdl-1) in Lung CancerLung CancerNCT05082636Assiut University90
已完成
不适用
Clinical Research for the Consistency Analysis of PD-L1 in Cancer Tissue and Plasma ExosomeNSCLCNCT02890849Xinqiao Hospital of Chongqing60
Unknown
不适用
Serum Autoantibodies in Predicting the Efficacy of Anti-PD-1 Treatment in Patients With Advanced NSCLCImmunotherapyLung CancerNCT04372732Shanghai Pulmonary Hospital, Shanghai, China200
已完成
不适用
A Translational Study Investigating PD-L1 Expression After Radiotherapy for Non-small Cell Lung CancerNon-Small Cell Lung CancerNCT03258788The Christie NHS Foundation Trust15